BioShares Biotechnology Price Prediction

BioShares Biotechnology Products -- USA Etf  

USD 40.65  0.54  1.31%

Macroaxis is not in business of monitoring BioShares Biotechnology headlines and social sentiment data; there are plenty of companies out there that do it quite successfully. However, we do analyze noise-free headlines and recent hype associated with BioShares Biotechnology Products brand which may create opportunities for some arbitrage if properly timed. With BioShares Biotechnology hype-based prediction module you can estimate the value of BioShares Biotechnology Products from the prospective of BioShares Biotechnology response to recently generated media hype and the effects of current headlines on its competitors. The module also provides analysis of price elasticity to changes in media outlook on BioShares Biotechnology over a specific investment horizon. Check also BioShares Biotechnology Basic Forecasting Models to cross-verify your projections.
 Time Horizon     30 Days    Login   to change

BioShares Biotechnology Estimiated After-Hype Price Volatility

 Next price density 
Expected price to next headline
January 17, 2018
Current Value
Downside upside
After-hype Price
Target Price Odds
 Above  Below  
Upside upside
BioShares Biotechnology is not too risky asset. Analysis and calculation of next after-hype price of BioShares Biotechnology is based on 1 month time horizon.

BioShares Biotechnology Hype Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.11% 1.07% 0.00%  0.04% 0 Events / Month1 Events / MonthIn 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility

BioShares Biotechnology Hype Timeline

On 17 of January BioShares Biotechnology Products is traded for 40.65. This company stock is not elastic to its hype. The average elasticity to hype of competition is 0.04. BioShares Biotechnology Products is estimated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is estimated to be very small where as daily expected return is currently at 0.11%. The volatility of relative hype elasticity to BioShares Biotechnology is about 319.4%%. The volatility of related hype on BioShares Biotechnology is about 319.4% with expected price after next announcement by competition of 40.69. The company has price-to-book (P/B) ratio of 1.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. BioShares Biotechnology Products had not issued any dividends in recent years. Considering 30-days investment horizon, the next estimated press release will be in 5 to 10 days.
Check also BioShares Biotechnology Basic Forecasting Models to cross-verify your projections.

BioShares Biotechnology Related Hype Analysis

Short fall
At Risk
Health Care Select Sector SPDR ETF(0.11) 1 per month 0.00  0.0861 (0.57)  1.12 (0.36)  1.49 
iShares Nasdaq Biotechnology(0.19) 1 per month 0.45 (0.0157) (0.72)  1.88 (1.23)  3.74 
Vanguard Health Care ETF 0.64 1 per month 0.00  0.11 (0.59)  1.24 (0.48)  1.77 
SPDR SP Biotech ETF 0.02 1 per month 1.44  0.11 (1.19)  2.56 (1.99)  5.86 
iShares US Healthcare 0.81 1 per month 0.00 (0.0157) (0.55)  1.13 (0.48)  1.62 
iShares Global Healthcare 0.84 1 per month 0.00 (0.0116) (0.52)  1.04 (0.45)  1.48